Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I by Yu. M. Lopatin, S. V. Nedogoda, M. V. Arkhipov, A. S. Galyavich, N. A. Koziolova, N. G. Lozhkina, E. V. Reznik, A. S. Salasyuk, M. Yu. Frolov, A. I. Chesnikova, E. V. Chumachek, L. A. Shpagina

Get full text

Heart Failure with Preserved Ejection Fraction in the Indian Context by Rajeev Gupta, Mahesh Choudhary, Soneil Guptha

“…Heart failure with preserved ejection fraction (HFpEF) is defined as a clinical syndrome with current or prior symptoms or signs caused by a structural or functional abnormality with left ventricular EF ≥50%, corroborated by either elevated natriuretic peptides or objective evidence of cardiogenic pulmonary or systemic congestion diagnosed with imaging or hemodynamic measurements. …”
Get full text

Investigation of gray matter volume in individuals with heart failure and preserved ejection fraction by Tianyi Yu, Qiuyun Bai, Yiting Guo, Yuchun Yuan

“…However, they maintained preserved systolic function and achieved lower scores on the MoCA, indicating deficits in visuospatial/executive functions, naming, attention, language, and memory. …”
Get full text

ALCAPA Presents in an Adult with Exercise Intolerance but Preserved Cardiac Function by Yan Liu, Beth W. Miller

“…She had normal left ventricular function without apparent ischemic cardiac symptoms eighteen months after procedure.…”
Get full text

Noninvasive identification and therapeutic implications of supernormal left ventricular contractile phenotype by Yi Wang, Lixue Yin

“…Left ventricular (LV) function is typically evaluated through LV ejection fraction (EF), a robust indicator of risk, showing a nonlinear increase in mortality rates below 40%. …”
Get full text

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE F... by I. V. Zhirov, O. A. Nikolaeva, S. N. Tereshchenko

Get full text

Predicting the risk of left ventricular diastolic dysfunction in obesity by G. A. Chumakova, O. V. Gritsenko, O. V. Gruzdeva, A. V. Zateev

“…After 4,7±0,3 years, echocardiography was repeated in order to assess LV diastolic function.Results.  Comparative analysis of metabolic risk factors revealed a significant increase in the level of total cholesterol (p=0,001), low-density lipoprotein cholesterol (LDL-C) (p<0,0001), triglycerides (TGs) (p<0,0001). …”
Get full text

Left Dominant Coronary Circulation is Associated with Poorer Left Ventricular Function but Not Long-Term Mortality After ST Elevation Myocardial Infarction by Yusuf Bozkurt Şahin, Emrullah Kızıltunç, Salih Topal, Adnan Abacı

“…Conclusion: Patients with left dominance had significantly lower left ventricular systolic function early after STEMI. …”
Get full text

Transient left ventricular function deterioration after patent ductus arteriosus closure: A case series by Mohammad Reza Sabri, Chehreh Mahdavi, Hamid Bigdelian, Ali Reza Ahmadi, Mehdi Ghaderian, Bahar Dehghan, Davood Ramezani Nezhad

“…Large patent ductus arteriosus is associated with more complications and reduced post-surgery cardiac function due to the amount of the shunt before closure.…”
Get full text

Extracellular matrix remodeling in patients with ischemic chronic heart failure with preserved ejection fraction by V. D. Syvolap, D. A. Lashkul

“…It was established that imbalance in the system MMP/TIMP in ischemic heart failure with preserved left ventricular ejection fraction leads to disruption of the extracellular matrix structural functional sufficiency, increases functional failure and is associated with impaired renal function. …”
Get full text

Imaging in Heart Failure with Preserved Ejection Fraction: A Multimodality Imaging Point of View by Serkan Ünlü, Özge Özden, Ahmet Çelik

“…HFpEF is an extremely complex syndrome and multimodality imaging is important for diagnosis, identifying its different phenotypes and determining prognosis. Evaluation of left ventricular filling pressures using echocardiographic diastolic function parameters is the first step of imaging in clinical practice. …”
Get full text

State of precision medicine for heart failure with preserved ejection fraction in a new therapeutic age by Roy Rasalam, Andrew Sindone, Gary Deed, Ralph G. Audehm, John J. Atherton

“…Two algorithms, the ‘Heavy, 2 or more Hypertensive drugs, atrial Fibrillation, Pulmonary hypertension, Elderly age >60, elevated Filling pressures’ (H2FPEF) and the ‘Heart Failure Association Pre‐test assessment, Echocardiography and natriuretic peptide, Functional testing, Final aetiology’ (HFA‐PEFF), can help to determine the likelihood of HFpEF in individuals with symptoms of HF. …”
Get full text

Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors by Erez Marcusohn, Ofer Kobo, Maria Postnikov, Danny Epstein, Yoram Agmon, Lior Gepstein, Yaron Hellman, Robert Zukermann

“…Results: Of 482 patients included in the final analysis, 80 (17%) had reduced and 402 (83%) had preserved LV function during the precardioversion transoesophageal echocardiography. …”
Get full text

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS by O. M. Drapkina, L. O. Palatkina

“…It makes conduct active searches for new biological markers of diastolic heart function. Participation of proinflammatory cytokines, in particular GDF-15, in the process of elasticity reduction and relaxation disorders of left ventricular myocardium, may be of great importance in the development of new medical agents designed to delay the progression of CHF with preserved ejection fraction.…”
Get full text

CORRELATION BETWEEN VAS OPRESSIN CONCENTRATION AND CHRONIC HEART FAILURE SEVE RITY: CHARAC TERISTICS OF PA TIENTS WITH TERMINAL AND DECOMPE NSA TED HEART FAILURE by E. S. Trofimov, A. S. Poskrebysheva, N. А. Shostak

“…A similar picture was observed for the functional classes (FC). For instance, for CHF FC II and III, the VP level was 91.93 ± 67.13 pg/ml and 77.95 ± 54.01 pg/ml respectively, while for FC IV it decreased to 50.49 ± 28.18 pg/ml (p <0.01). …”
Get full text

Myocardial electrical activity according to daily ECG monitoring in patients with heart failure with preserved ejection fraction and asymptomatic diastolic dysfunction by V. D. Syvolap, Ya. V. Zemlyaniy, E. V. Nazarenko

“…For evaluating changes in the electrical activity of the myocardium and study their relationship with those structural and functional condition of the heart in 36 patients with preserved left ventricular ejection fraction after myocardial infarction with hypertension the next methods were used: ECG monitoring, echocardiography and serum NTproBNP level detection. …”
Get full text

The oxytocin-oxytocin receptors system — a new pathogenetic mechanism in the development of diabetic phenotype of heart failure with preserved ejection fraction in women by A. D. Starchenko, Yu. V. Liskova, A. A. Stadnikov

“…To determine the pathogenetic role of the oxytocinergic system in the development of myocardium structural and functional changes in women with heart failure with preserved ejection fraction (HFpEF) associated with type 2 diabetes mellitus (DM2T) (diabetic phenotype of HFpEF).Material and methods. …”
Get full text

Therapeutic Efficacy of Alpha-Lipoic Acid against Acute Myocardial Infarction and Chronic Left Ventricular Remodeling in Mice by Zequan Yang, Yikui Tian, Stuart S. Berr, Brent A. French

“…Daily oral ingestion of ALA not only protects mice against AMI but also attenuates LVR and preserves contractile function in the months that follow.…”
Get full text

Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction by Jane Draper, Antonio De Marvao, Robert M Cooper, Gerry Carr-White, Nabeel Sheikh, Rachel Bastiaenen, Yande Kasolo, Jason N Dungu, Edward Burford

“…Eligibility criteria included New York Heart Association (NYHA) class II–III symptoms and LVOT gradients >30 mm Hg with normal left ventricular ejection function (LVEF >55%), as per National Institute for Health and Care Excellence guidelines and product literature. …”
Get full text

DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY by An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova

“…To evaluate the association of serum resistin with morphological and functional indices of hypertrophic myocardium in patients with type 2 diabetes and chronic heart failure (CHF) with preserved left ventricular ejection fraction.Material and methods. …”
Get full text